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The success of root canal treatment depends on the elimination of bacteria by chemo-mechanical instrumentation and use 
of various irrigants to remove or dissolve organic and inorganic debris.The intracanal medicament also has an important role 
in the outcome of root canal treatment. With the rise in bacterial resistance to antibiotics, there is considerable interest in the 
development of other classes of antimicrobials for the control of infection. Use of Herbal intracanal medicament has been 
shown promising results when used under in vitro conditions, but very limited clinical trials reported due to the ethical 
concern. Hence, this review highlights the current guidelines (laid by the drugs and cosmetics act as per the Gazette of India) 
regarding the use of herbal medicaments for the clinical trials in Endodontics. 
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Introduction 
The main goal of endodontic therapy is to disinfect 
the root canal system and to fill it in all its dimensions1. 
This involves the use of chemically active solutions 
along with mechanical instrumentation of the root canal 
system2. However, it has been proved that mechanical 
instrumentation with antibacterial irrigation causes only 
50–70% of infected canals free of microorganisms. 
Hence, additional methods such as the use of intracanal 
medicaments are required to maximize disinfection of 
the root canal system and kill as many bacteria as 
possible3. 
The intracanal medicament plays a key role in the 
success of root canal treatment. With the rise in bacterial 
resistance to antibiotics, there is a considerable increase 
in the interest in the development of other classes of 
antimicrobials for the control of infection. In the search 
for novel irrigants and intracanal medicaments with 
good biocompatibility and antimicrobial activity, 
researchers have explored several potential agents of 
natural origin. Evaluation of antimicrobial activity of 
neem, propolis, turmeric, liquorice, grape seed extracts, 
Triphala, Green tea polyphenols (GTP) has shown good 
results as compared to that of sodium hypochlorite as 
root canal irrigants4-6. India has a rich source of 
medicinal plants that are widely distributed throughout 
the country7. 
Even though the use of herbal intracanal medicament 
has been shown promising results when used under in 
vitro conditions8-11, but in vivo studies are very 
limited12,13. This may be due to the scarce literature 
available to use it as intracanal medicament under in 
vivo conditions due to the ethical concern. Hence, the 
goal of the present paper is to focus on the current 
guidelines and literature regarding the use of herbal 
medicaments for in vivo clinical trials in Endodontics. 
Natural substitutes used in dentistry 
These are generally classified into three groups, 
namely plant products, animal products, and mineral 
origin14. In dentistry, they are used as antimicrobial 
agents, anti-inflammatory agents and sedative & 
anxiolytics.  
The miscellaneous uses include endodontic irrigants, 
medicaments. Herbal extracts have been used in 
dentistry for reducing inflammation15, as antimicrobial 
plaque agents16, for preventing the release of histamine 
and asantiseptics17, antioxidants18, antimicrobials8, 










The prime benefits of using herbal alternatives in 
dentistry are cost‑ effectiveness, readily available, less 
toxic and lack of microbial resistance reported so far. 
Even though the results of in vitro studies appear 
promising, there are very few studies reported to 
evaluate clinical efficacy and safety factor12-13. 
The Drugs & Cosmetics Act, 1940 and Rules 1945 
have entrusted various responsibilities to central & 
state regulators for the regulation of drugs and 
cosmetics. It envisages uniform implementation of the 
provisions of the Act & Rules made thereunder for 
ensuring the safety, rights, and well being of the 
patients by regulating the drugs and cosmetics. 
 
Central Drugs Standard Control Organisation 
(CDSCO) 
The CDSCO is responsible for approval and 
regulation of New Drugs and Clinical Trials in the 
country, laying down the standards for Drugs, control 
over the quality of imported Drugs, coordination of 
the activities of State Drug Control Organizations and 
providing expert advice with a view of bring about the 
uniformity in the enforcement of the Drugs and 
Cosmetics Act. Under Directorate General of Health 
Services, Ministry of Health & Family Welfare, 
Government of India is the National Regulatory 
Authority (NRA) of India. Its headquarter is located at 
FDA Bhawan, New Delhi, and also has six zonal 
offices, four sub zonal offices, thirteen Port offices 
and seven laboratories spread across the country20. 
 
The Drugs Controller General of India (DCGI) 
DCGI is an official of the CDSCO who is the final 
regulatory authority for the approval of clinical trials 
in the country. His ambit also extends to inspections 
of trial sites, inspections of sponsors of clinical 
research and manufacturing facilities in the country, 
oversight of the Central Drugs Testing Laboratory 
(Mumbai) and the Regional Drugs Testing Laboratory 
as also heading the Indian Pharmacopeia Commission 
among various other roles, responsibilities, and 
functions. DCGI monitors the quality of manufacturing, 
marketing, import, and distribution of drugs in India. 
It monitors any dispute regarding the quality of drugs 
and maintains uniformity in the enforcement of the 
Drugs and Cosmetics Act. All the research institutes 
conducting research are under the direct supervision 
of DCGI20. 
 
Academic clinical trial 
All clinical trials need to have approval from the 
Institutional Ethical Committee. No permission for 
conducting an academic clinical trial is required for 
any drug from the Central Licencing Authority 
where,― (i) the clinical trial in respect of the 
permitted drug formulation is intended solely for 
academic research purposes for a new indication or 
new route of administration or new dose or new 
dosage form; and (ii) the clinical trial referred to in 
clause (i) has been initiated after prior approval by the 
Ethics Committee for a clinical trial; and (iii) the 
observations generated from such clinical trial are not 
required to be submitted to the Central Licencing 
Authority; and (iv) the observations of such clinical 
trial are not used for promotional purposes21. 
 
Clinical Trials Registry of India (CTRI) 
The CTRI is a free, online portal that allows both 
investigator-initiated and regulatory studies to be 
registered. It is recommended that all studies are 
registered at a public portal. However, for Regulatory 
Clinical Trials, registration in CTRI is mandatory 
from June 200921. Registration must be done before 
the first participant is enrolled, Registration is 
important from a publication standpoint, as editors of 
many Biomedical Journals will not accept papers that 
have interventional studies not registered with a 
Clinical Trials Registry22. 
 
The current guidelines for use of herbal 
medicaments in a clinical trial 
Indian Government has already recognized 
Ayurveda to be practised as the official system of 
medicine. In India, rules for practice and education of 
Ayurveda have been laid in 1970 by the Indian 
Medicine Central Act whereas herbal medicines of 
Ayurveda are governed by Drugs and Cosmetics Act 
1940 (Chapter IV A)23. The Gazette of India on 30 
Nov 2015 in a notification by the Ministry of Health 
and Family welfare has made following amendment 
in the Drugs and Cosmetics Rules, 1945, namely:- 
“In rule 2 of the Drugs and Cosmetics Rules,  
1945 (hereinafter referred to as the said rules), after 
clause (ea) the following clause shall be inserted, 
namely:—‘(eb). “Phytopharmaceutical drug” includes 
purified and standardized fraction with defined 
minimum four bio-active or phyto-chemical compounds 
(qualitatively and quantitatively assessed) of an extract 
of a medicinal plant or its part, for internal or external 
use of human beings or animals for diagnosis, 
treatment, mitigation or prevention of any disease or 
disorder but does not include administration by 
parenteral route”24. 





In Indian regulations, herbal drugs are regulated 
under the Drug and Cosmetic Act 1940 and Rules 
1945, where regulatory provisions for Ayurveda, 
Unani, Siddha medicine are clearly laid down. 
Department of AYUSH is the regulatory authority and 
mandate that any manufacture or marketing of herbal 
drugs have to be done after obtaining manufacturing 
license, as applicable. There are two major classes of 
Herbal products25. 
 
Classical Ayurveda drugs 
Classical Ayurveda drugs as mentioned in the 
authoritative books of Ayurveda system, which are 
manufactured and named in accordance with the 
formulations described in the authoritative texts. 
These classes of Herbal medicaments do not require 
the approval from the DCGI for conducting the 
clinical trial. However, a clinical trial registration 
should be done after obtaining approval from the 
Institutional Ethical Committee of the research 
institute or university. 
 
Patent or proprietary medicine 
Patent or proprietary medicine makes use of 
ingredients referred in the formulations of 
authoritative texts but with intellectual intervention, 
innovation or invention to manufacture products 
different from the classical medicine26. 
 
Conclusion 
The herbal products today symbolize safety in 
contrast to the synthetics that are regarded as unsafe 
to humans and the environment. Hence, to avoid 
antibiotic abuse as well as the development of microbial 
resistance, the researchers in dentistry can utilize the 
integration of Ayurvedic and other Indian traditional 
medicine in clinical practice, especially in endodontics. 
Proper monitoring of these medicaments periodic 
revisions of the regulations needs to be done to avoid 
irrational use, quality control and standardization 
issues to promotethe use of herbal medicaments in 
Endodontics. 
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